EMCDDA news

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic cannabinoid reported in the EU and has been monitored as a NPS by the EU Early Warning System since 21 October 2022. 19.12.2022 
Čtěte více

Czech EU Presidency: a human rights-based approach to drug policy

This month, the Czech six-month Presidency of the Council of the EU draws to a close. With the motto ‘Rebuild, Rethink, Repower’, the Presidency focused on five key priorities: managing the refugee crisis and post-war reconstruction of Ukraine; energy security; strengthening European defence capabilities and cybersecurity; strategic resilience of the European economy; and the resilience of democratic institutions. 19.12.2022 
Čtěte více

Service awards for four long-standing members of the EMCDDA Management Board

Four long-standing members of the EMCDDA Management Board received awards this week in recognition of their extraordinary dedication and service to the agency. The recipients were:  Mr Franz Pietsch — Chairman of the Management Board since 1 January 2022. Mr Pietsch has been Austrian member of the Board since 2002. He is currently Deputy Director-General and Head of the Human Medicines Law Division at the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection. 16.12.2022 
Čtěte více

Belgian Interior Minister visits EMCDDA for talks on public safety and security

Belgian Minister of the Interior, Institutional Reform and Democratic Renewal, Ms Annelies Verlinden, visited the EMCDDA this week during an official visit to Portugal. The Minister met EMCDDA Director Alexis Goosdeel who presented the work of the agency and its upcoming change of mandate. The focus of the visit was on public safety and security. 13.12.2022 
Čtěte více

EMCDDA participates in Latin American regional meeting on early warning systems

This week, the EMCDDA participated in a meeting ‘Early warning systems in response to opioids and new psychoactive substances’, organised by the Inter-American Drug Abuse Control Commission (CICAD) of the Organisation of American States (OIS) and the Canadian authorities (1). The agency participated remotely in the event, which was held in Port of Spain, Trinidad and Tobago (7–8 December). 09.12.2022 
Čtěte více

Families and homelessness — two new EMCDDA miniguides on responding to drug problems, launched today

Responding to drug problems in families and among those experiencing homelessness is the focus of two new EMCDDA miniguides released today. The resources are the first of five volumes dedicated to people with vulnerability and form part of the agency’s Health and social responses to drug problems: a European guide. 08.12.2022  HEALTH AND SOCIAL RESPONSES TO DRUG PROBLEMS: A EUROPEAN GUIDE
Čtěte více

Nepřehlédněte: 29. 2. 2024 jsme zveřejnili Zprávu o alkoholu v ČR 2023 a Zprávu o tabákových a nikotinových výrobcích v ČR 2023  zde na homepage